Mice_NNS
lacking_VBG
the_DT
transcription_NN
factor_NN
CIITA_NN
--_:
a_DT
second_JJ
look_NN
._.

We_PRP
have_VBP
generated_VBN
a_DT
second_JJ
line_NN
of_IN
mice_NNS
lacking_VBG
a_DT
transcription_NN
factor_NN
thought_VBN
to_TO
be_VB
a_DT
critical_JJ
regulator_NN
of_IN
MHC_NN
class_NN
II_CD
gene_NN
expression_NN
,_,
CIITA_NN
-LRB-_-LRB-
for_IN
class_NN
II_CD
transactivator_NN
-RRB-_-RRB-
._.

Our_PRP$
and_CC
the_DT
previously_RB
published_VBN
lines_NNS
differ_VBP
in_IN
the_DT
deletion_NN
that_WDT
was_VBD
engineered_VBN
and_CC
by_IN
the_DT
fact_NN
that_IN
we_PRP
removed_VBD
the_DT
neomycin-resistance_JJ
promoter_NN
and_CC
structural_JJ
gene_NN
via_IN
the_DT
cre-loxP_JJ
recombination_NN
system_NN
._.

Characterization_NN
of_IN
our_PRP$
line_NN
led_VBD
to_TO
two_CD
new_JJ
findings_NNS
._.

First_RB
,_,
a_DT
substantial_JJ
number_NN
of_IN
cells_NNS
can_MD
express_VB
class_NN
II_CD
molecules_NNS
in_IN
the_DT
absence_NN
of_IN
CIITA_NN
,_,
albeit_IN
at_IN
5-fold_RB
reduced_VBN
levels_NNS
,_,
most_RBS
notably_RB
dendritic_JJ
cells_NNS
in_IN
s.c._NN
lymph_NN
nodes_NNS
;_:
therefore_RB
,_,
the_DT
CIITA_NN
gene_NN
can_MD
not_RB
be_VB
an_DT
absolute_JJ
'_``
master_JJ
gene_NN
'_''
controlling_VBG
the_DT
expression_NN
of_IN
class_NN
II_CD
molecules_NNS
,_,
as_IN
had_VBD
been_VBN
thought_VBN
._.

Second_RB
,_,
in_IN
contrast_NN
to_TO
recent_JJ
results_NNS
on_IN
human_JJ
cell_NN
lines_NNS
,_,
CIITA_NN
is_VBZ
not_RB
critically_RB
involved_VBN
in_IN
the_DT
IFN-gamma-induced_JJ
up-regulation_NN
of_IN
MHC_NN
class_NN
I_CD
genes_NNS
._.

